Arbutus Biopharma Insider Trades

ABUS

Track insider trading activity from Arbutus Biopharma executives and directors. See which insiders are buying and selling ABUS stock.

Trades Last 12 Months

All Insider Trades for Arbutus Biopharma

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Androski Lindsay President And CEO
Holding Value $312k 71,700 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$438k 99,700 shares
$4.39
$4.35
Nguyen Tuan Chief Financial Officer
Holding Value $820k 188,400 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.15M 261,900 shares
$4.39
$4.35
Holding Value $686k 157,600 shares
Last Trade
Mar 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$504k 157,600 shares
$3.20
$4.35
Hasija Anuj Director
Holding Value $686k 157,600 shares
Last Trade
Mar 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$504k 157,600 shares
$3.20
$4.35
Naftzger J. Christopher General Counsel And CCO
Holding Value $958k 220,300 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$725k 220,300 shares
$3.29
$4.35
Sims Karen Chief Medical Officer
Holding Value $871k 200,300 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$659k 200,300 shares
$3.29
$4.35
Mcelhaugh Michael J. Interim President & CEO
Holding Value $7.21M 1,658,003 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.36M 718,800 shares
$3.29
$4.35
Hastings David C Chief Financial Officer
Holding Value $1.59M 365,800 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 365,800 shares
$3.29
$4.35
Holding Value $239k 54,915 shares
Last Trade
Aug 14, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$202k 54,915 shares
$3.68
$4.35
Meyers James R Director
Holding Value $291k 67,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 67,000 shares
$3.28
$4.35
Burgess Daniel D Director
Holding Value $291k 67,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 67,000 shares
$3.28
$4.35
Holding Value $291k 67,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 67,000 shares
$3.28
$4.35
Holding Value $291k 67,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 67,000 shares
$3.28
$4.35
Torti Frank Director
Holding Value $291k 67,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 67,000 shares
$3.28
$4.35
Sofia Michael J. Chief Scientific Officer
Holding Value $6.46M 1,485,121 shares
Last Trade
Feb 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$23.1k 9,982 shares
$2.31
$4.35
Howard Elizabeth Evp, Gc, Compliance
Holding Value $1.21M 278,700 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.01M 348,400 shares
$2.90
$4.35
Collier William H. President And CEO
Holding Value $3.77M 866,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.14M 1,082,500 shares
$2.90
$4.35
Mc Elhaugh Michael J. Chief Business Officer
Holding Value $1.46M 334,700 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$971k 334,700 shares
$2.90
$4.35
Tran Tram Director
Holding Value $178k 41,000 shares
Last Trade
May 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$92.3k 41,000 shares
$2.25
$4.35
Picchio Gaston Chief Development Officer
Holding Value $1.12M 256,500 shares
Last Trade
Jan 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$721k 256,500 shares
$2.81
$4.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up